A system wiring itself up
France's healthcare system runs on paper less and less. The shift has been deliberate — and state-led. Since the early 2020s, the government has pushed a cluster of digital reforms at once: an electronic prescription platform, a national personal health space, and an accelerating startup ecosystem, all backed by significant public investment channelled through Bpifrance and the broader France 2030 plan.
The most visible change for most patients is the ordonnance numérique — the e-prescription. Rolled out progressively from 2022, it replaces the iconic paper slip with a QR code transmitted directly to pharmacies. The practical effect is modest friction removal: no lost prescriptions, no illegible handwriting, a cleaner audit trail for reimbursement. For the Assurance Maladie, the national health insurance body, it also means better data on prescribing patterns.
Running alongside it is Mon Espace Santé, the opt-out personal health space launched in 2022. Every person covered by French health insurance gets one automatically. It holds test results, vaccination records and, eventually, a summary from the médecin traitant. Adoption has been uneven — opening a space is not the same as using it — but the platform crossed tens of millions of registered users within its first two years.
The startup layer
Below the state infrastructure sits a growing private ecosystem. France now hosts several hundred digital-health companies, concentrated in Paris but with clusters in Lyon and Bordeaux. Their products range from remote-monitoring devices for chronic-disease patients to AI-assisted imaging tools used in hospital radiology departments. A handful have reached scale: Doctolib, the appointment-booking platform used by the majority of French GPs and specialists, is the most widely known.
What distinguishes the French model from purely market-driven systems is the gatekeeping role of the state. A startup's product can be reimbursed only if it obtains a marquage CE and, increasingly, navigates the Article 51 experimental framework or the dedicated digital-medical-device track — a slow but legitimising process that filters out the flimsier consumer apps.
The honest picture is still one of promise and friction in roughly equal measure. Interoperability between hospital systems, GP software and Mon Espace Santé remains incomplete. Data-sharing rules, while protective of privacy, can complicate the seamless record transfer that would make a fully connected system real. France is building the infrastructure faster than it is filling it with useful data — a common pattern in health digitisation everywhere, and a reminder that the technology is rarely the hardest part.
